Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM
Rohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, Phyllis M. Thangaraj, Aline Pedroso Camargos, Fan Bu, Xiyu Ding, Akihiko Nishimura, Tara V. Anand, Faaizah Arshad, Clair Blacketer, Yi Chai, Shounak Chattopadhyay, Michael Cook, David A. Dorr, Talita Duarte-Salles, Scott L. DuVall, Thomas Falconer, Tina E. French, Elizabeth E. HanchrowGuneet Kaur, Wallis C.Y. Lau, Jing Li, Kelly Li, Yuntian Liu, Yuan Lu, Kenneth K.C. Man, Michael E. Matheny, Nestoras Mathioudakis, Jody Ann McLeggon, Michael F. McLemore, Evan Minty, Daniel R. Morales, Paul Nagy, Anna Ostropolets, Andrea Pistillo, Thanh Phuc Phan, Nicole Pratt, Carlen Reyes, Lauren Richter, Joseph S. Ross, Elise Ruan, Sarah L. Seager, Katherine R. Simon, Benjamin Viernes, Jianxiao Yang, Can Yin, Seng Chan You, Jin J. Zhou, Patrick B. Ryan, Martijn J. Schuemie, Harlan M. Krumholz, George Hripcsak, Marc A. Suchard
Dive into the research topics of 'Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM'. Together they form a unique fingerprint.